Our Advisory Board serves as a brain trust, offering
leadership, industry contacts and resources
Brian J. Brille is the President of the Asia Pacific Region for Banc of
America Merrill Lynch. Mr. Brille was previously a Managing Director and
Head of Healthcare Services Investment Banking at Morgan Stanley & Co., Inc.
Andrew Brooks, Ph.D., is currently the Chief Operating Officer of the Rutgers University Cell and DNA Repository (RUCDR) and Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses. He has worked to automate the RUCDR and build the service entity that provides high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally.
Steven B. Epstein, Esq. is the founder of Epstein Becker & Green, P.C., one of the largest national healthcare law firms in the United States. As a Senior Partner of the firm, he provides health care organizations and providers with strategic legal guidance on a range of issues and legal challenges relating to the American health care system. Mr. Epstein currently sits on the boards of a number of health care companies, including Healthsense, Inc., and Management Health Solutions, Inc., both Radius portfolio companies, and Accelion, LLC, MedExpress, Inc., Discovery Health, Inc, HealthExtras, Inc. and Emergency Medical Services Corporation.
Scott T. Garrett is the former President and Chief Executive Officer of Beckman Coulter, Inc., one of the world’s largest manufacturers of biomedical tests, instrumentation and supplies. Previously, Mr. Garrett served as Chief Executive Officer of Garrett Capital Advisors, LLC, Kendro Laboratory Products, and Dade Behring (a spinout of Baxter International). His prior experience also includes leadership positions at Baxter International and American Hospital Supply Corporation.
William A. Hawkins is the former President and Chief Executive Officer of Medtronic, Inc. Previously, he has held the positions of President and CEO of Novoste Corporation; President of Sherwood Davis & Geck, (a subsidiary of American Home Products); President of Ethicon Endo-Surgery, Inc. (subsidiary of Johnson & Johnson); President and CEO of IVAC, an Eli Lilly subsidiary, and President of Devices for Vascular Intervention of Guidant (following its spin-off from Eli Lilly).
Javier Lopez Madrid is an Executive Director of the Villar Mir Group, one of the largest privately-held industrial holding groups in Spain. Mr. Lopez Madrid is also the founder and Chairman of STH Capital, a venture capital partnership focused on the biotechnology, financial services and telecommunications industries.
David McGibney, MB, Ch.B., FRCP, FFPM joined Pfizer in Europe in 1982 and was appointed head of European Clinical Development for Pfizer Central Research in 1992. He was later named Vice President of Clinical Research and a member of the Board of Directors of Pfizer Ltd., in 1995. Prior to leaving Pfizer in 2001, he was Senior Vice President of Pfizer Global Research and Development and Director of the R & D Laboratories in Sandwich, Kent, UK. Dr. McGibney is the former Chairman of the Development Advisory Board of Athersys, Inc., a Radius portfolio company.
James I. McLaren is a Managing Director of Asanté Partners, LLC, an investment banking business which he founded in 1992 at EGS Securities Corp. He is also a Member of EGS Private Healthcare Associates, LLC, a private equity investment fund, and was formerly director of RTP Pharma, Inc., a drug delivery company that was purchased by SkyePharma plc.
Dilip J. Mehta, M.D., Ph.D. has been affiliated with Radius Ventures since 2002. Previously, Dr. Mehta served as Senior Vice President of U.S. Clinical Research at Pfizer, Inc., where he was responsible for Phase I, II and III clinical research, including the design and implementation of clinical protocols, statistical analysis, data processing, and submissions of New Drug Applications ("NDA") for Pfizer's pharmaceutical pipeline. During Dr. Mehta's tenure at Pfizer, he supervised NDA submissions for many of the company's previously top-selling drugs, including Norvasc™, Zoloft™, Zithromax™, Diflucan™ and Viagra™. Dr. Mehta previously served on the board of Targanta, Inc., which was a Radius portfolio company, and was on the boards of a number of U.S. and international biotechnology companies. Dr. Mehta has also served on the board of the Psychopharmacology Advisory Committee of the FDA.
Thomas F. O'Donnell, Jr., M.D. is the former President and CEO of the Tufts New England Medical Center and is currently the Senior Vascular Surgeon at Tufts New England and the Benjamin Andrews Professor of Surgery Emeritus at Tufts University School of Medicine.
Mehmet C. Oz, M.D. is the Vice-Chairman of Surgery and Irving Professor of Cardiac Surgery at Columbia University and directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital. He has authored five New York Times Best Sellers, over 400 original publications, book chapters and medical books, has a regular column in Esquire and O magazines and has received several patents. For five years, he served as the Health Expert on The Oprah Winfrey Show and is now host of syndicated talk show, "The Dr. Oz Show" and a daily talk show on Sirius XM Radio's "Oprah & Friends." Dr. Oz is also the founder and Chairman of HealthCorps, a proactive health movement dedicated to educating and empowering youth to take charge of their health.
Stephen G. Pagliuca is a Managing Director of Bain Capital and has helped build the firm into one of the world’s leading investment companies with more than $40 billion under management. He is the co-managing partner and co-owner of the Boston Celtics, and serves on the corporate boards of Hospital Corporations of America (HCA), Gartner Group, Burger King Corporation, ProSiebenSat 1 Media AG and Warner Chilcott.
David R. Pitts has been President and Chief Executive Officer of Pitts Management Associates, Inc. ("PMA") since 1981 and Chairman and Chief Executive Officer of PMA since 1999. PMA is a national hospital and healthcare management and consulting firm. Mr. Pitts has over forty years experience in hospital operations, healthcare planning and multi-institutional organizations, and has served in executive capacities in a number of hospitals, multi-hospital systems and medical schools. He also serves as Chairman of the Board of Directors of Business First Bank of Louisiana, Chairman of the Board of Trustees of General Health Corporation and Chair of the Church Pension Group in New York City and is a member of the North American Advisory Board of Sodexo. He is certified in hospital and healthcare administration and is a Fellow of the American College of Healthcare Executives.
Jan Rock became has been affiliated with Radius Ventures since 2002. Previously, Ms. Rock served as Vice President of Women's Health at Johnson & Johnson ("J&J"). At J&J, she was responsible for expanding the company’s two billion dollar franchise in women's health products, which resulted in the $290 million acquisition of Biopsys Medical, the $79 million acquisition of Gynecare, Inc., and the creation of a new J&J venture, Women's First Healthcare. Ms. Rock currently serves on the board of directors of U-Systems, Inc., a Radius portfolio company. She has also served as a director or observer to several venture stage companies, including Amicas, Inc. and BEI Medical, Inc., both Radius portfolio companies, as well as Immunicon, Inc., Protocare, Inc., and Purilens, Inc.
Vinod K. Sahney, Ph.D. is Senior Fellow at the Institute for Health Care Improvement (IHI). His previous positions include Senior Vice President and Chief Strategy Officer at Blue Cross Blue Shield of Massachusetts (2006-2010) and Senior Vice President at Henry Ford Health System (1981-2006). Dr. Sahney has been elected to both the Institute of Medicine and The National Academy of Engineering. He has served as an Adjunct Professor at Harvard University's Executive Program in Health Policy and Management for the past 33 years. He has served on several Boards including the Institute for Health Care Improvement, St. Joseph Mercy Hospital-Oakland, Fairlane Health Services Corporation, Society for Health Systems, Washington University School of Medicine Faculty Practice Plan, St. Joseph Macomb Hospital, Michigan Childrens, Henry Ford, Optimeyes and Healthsense, Inc., a Radius portfolio company. He has served on a number of National Research Advisory Boards including AHRQ, NSF, NAE and IOM. He has also authored two books, 50 publications and over 200 presentations at national and international meetings. He has been a management consultant to over 30 health care organizations in the area of strategy, productivity and quality improvement.
Leon G. Smith, M.D. is Chairman of Medicine and former Chief of Infectious Diseases at St. Michael’s Medical Center in Newark, NJ. He is also Chairman of Medicine at the Seton Hall University School of Graduate Medical Education and Professor of Preventative Medicine at New Jersey Medical School.
Mark S. Speers is Managing Director and co-founder of Health Advances, LLC, a strategy consulting firm focused on the evaluation and commercialization of new medical technologies and services. Previously, Mr. Speers served as a Partner at Bain & Company where he consulted for major health and life sciences companies.
Arthur H. Spiegel III founded APM Management Consultants in 1974 and grew the firm into the nation's largest stand-alone consulting firm dedicated to healthcare. In 1996, he sold APM to CSC, where, as President, he established and built the CSC Healthcare Group into one of the top four technology service companies in the industry. He also served in top management capacities for the city of New York and was one of the early leaders of ACCION International, a community development program. He currently sits on the boards of Accretive Health, Inc., Silverlink Communications, Inc., Sound Inpatient Physicians, Accolade Inc. and BioStorage, Inc., a Radius portfolio company.
Barry W. Wilson is the former Senior Vice President, International of Medtronic, Inc. He joined Medtronic, Inc. in 1995, as President Europe, Middle East & Africa. Previously, Mr. Wilson held executive-level positions with American Cyanamid Company (President, International of the Lederle Division), Bristol-Myers Squibb (President, Europe) and Pfizer. He currently serves as Honorary Chairman of Eucomed, the pan-European medical technology trade association, and has been a senior advisor to AdvaMed, the U.S. medical device association. Mr. Wilson was the former Chairman of Heartscape, Inc., a Radius portfolio company.
Andrew Brooks, Ph.D., is currently the Chief Operating Officer of the Rutgers University Cell and DNA Repository (RUCDR) and Director of the Bionomics Research and Technology Center (BRTC) at the Environmental and Occupational Health Science Institute of the University of Medicine and Dentistry of New Jersey. He is an Associate Professor of Environmental Medicine and Genetics at UMDNJ/Rutgers. Dr. Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. These studies investigate gene-environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses. He has worked to automate the RUCDR and build the service entity that provides high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally.
Steven B. Epstein, Esq. is the founder of Epstein Becker & Green, P.C., one of the largest national healthcare law firms in the United States. As a Senior Partner of the firm, he provides health care organizations and providers with strategic legal guidance on a range of issues and legal challenges relating to the American health care system. Mr. Epstein currently sits on the boards of a number of health care companies, including Healthsense, Inc., and Management Health Solutions, Inc., both Radius portfolio companies, and Accelion, LLC, MedExpress, Inc., Discovery Health, Inc, HealthExtras, Inc. and Emergency Medical Services Corporation.
Scott T. Garrett is the former President and Chief Executive Officer of Beckman Coulter, Inc., one of the world’s largest manufacturers of biomedical tests, instrumentation and supplies. Previously, Mr. Garrett served as Chief Executive Officer of Garrett Capital Advisors, LLC, Kendro Laboratory Products, and Dade Behring (a spinout of Baxter International). His prior experience also includes leadership positions at Baxter International and American Hospital Supply Corporation.
William A. Hawkins is the former President and Chief Executive Officer of Medtronic, Inc. Previously, he has held the positions of President and CEO of Novoste Corporation; President of Sherwood Davis & Geck, (a subsidiary of American Home Products); President of Ethicon Endo-Surgery, Inc. (subsidiary of Johnson & Johnson); President and CEO of IVAC, an Eli Lilly subsidiary, and President of Devices for Vascular Intervention of Guidant (following its spin-off from Eli Lilly).
Javier Lopez Madrid is an Executive Director of the Villar Mir Group, one of the largest privately-held industrial holding groups in Spain. Mr. Lopez Madrid is also the founder and Chairman of STH Capital, a venture capital partnership focused on the biotechnology, financial services and telecommunications industries.
David McGibney, MB, Ch.B., FRCP, FFPM joined Pfizer in Europe in 1982 and was appointed head of European Clinical Development for Pfizer Central Research in 1992. He was later named Vice President of Clinical Research and a member of the Board of Directors of Pfizer Ltd., in 1995. Prior to leaving Pfizer in 2001, he was Senior Vice President of Pfizer Global Research and Development and Director of the R & D Laboratories in Sandwich, Kent, UK. Dr. McGibney is the former Chairman of the Development Advisory Board of Athersys, Inc., a Radius portfolio company.
James I. McLaren is a Managing Director of Asanté Partners, LLC, an investment banking business which he founded in 1992 at EGS Securities Corp. He is also a Member of EGS Private Healthcare Associates, LLC, a private equity investment fund, and was formerly director of RTP Pharma, Inc., a drug delivery company that was purchased by SkyePharma plc.
Dilip J. Mehta, M.D., Ph.D. has been affiliated with Radius Ventures since 2002. Previously, Dr. Mehta served as Senior Vice President of U.S. Clinical Research at Pfizer, Inc., where he was responsible for Phase I, II and III clinical research, including the design and implementation of clinical protocols, statistical analysis, data processing, and submissions of New Drug Applications ("NDA") for Pfizer's pharmaceutical pipeline. During Dr. Mehta's tenure at Pfizer, he supervised NDA submissions for many of the company's previously top-selling drugs, including Norvasc™, Zoloft™, Zithromax™, Diflucan™ and Viagra™. Dr. Mehta previously served on the board of Targanta, Inc., which was a Radius portfolio company, and was on the boards of a number of U.S. and international biotechnology companies. Dr. Mehta has also served on the board of the Psychopharmacology Advisory Committee of the FDA.
Thomas F. O'Donnell, Jr., M.D. is the former President and CEO of the Tufts New England Medical Center and is currently the Senior Vascular Surgeon at Tufts New England and the Benjamin Andrews Professor of Surgery Emeritus at Tufts University School of Medicine.
Mehmet C. Oz, M.D. is the Vice-Chairman of Surgery and Irving Professor of Cardiac Surgery at Columbia University and directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital. He has authored five New York Times Best Sellers, over 400 original publications, book chapters and medical books, has a regular column in Esquire and O magazines and has received several patents. For five years, he served as the Health Expert on The Oprah Winfrey Show and is now host of syndicated talk show, "The Dr. Oz Show" and a daily talk show on Sirius XM Radio's "Oprah & Friends." Dr. Oz is also the founder and Chairman of HealthCorps, a proactive health movement dedicated to educating and empowering youth to take charge of their health.
Stephen G. Pagliuca is a Managing Director of Bain Capital and has helped build the firm into one of the world’s leading investment companies with more than $40 billion under management. He is the co-managing partner and co-owner of the Boston Celtics, and serves on the corporate boards of Hospital Corporations of America (HCA), Gartner Group, Burger King Corporation, ProSiebenSat 1 Media AG and Warner Chilcott.
David R. Pitts has been President and Chief Executive Officer of Pitts Management Associates, Inc. ("PMA") since 1981 and Chairman and Chief Executive Officer of PMA since 1999. PMA is a national hospital and healthcare management and consulting firm. Mr. Pitts has over forty years experience in hospital operations, healthcare planning and multi-institutional organizations, and has served in executive capacities in a number of hospitals, multi-hospital systems and medical schools. He also serves as Chairman of the Board of Directors of Business First Bank of Louisiana, Chairman of the Board of Trustees of General Health Corporation and Chair of the Church Pension Group in New York City and is a member of the North American Advisory Board of Sodexo. He is certified in hospital and healthcare administration and is a Fellow of the American College of Healthcare Executives.
Jan Rock became has been affiliated with Radius Ventures since 2002. Previously, Ms. Rock served as Vice President of Women's Health at Johnson & Johnson ("J&J"). At J&J, she was responsible for expanding the company’s two billion dollar franchise in women's health products, which resulted in the $290 million acquisition of Biopsys Medical, the $79 million acquisition of Gynecare, Inc., and the creation of a new J&J venture, Women's First Healthcare. Ms. Rock currently serves on the board of directors of U-Systems, Inc., a Radius portfolio company. She has also served as a director or observer to several venture stage companies, including Amicas, Inc. and BEI Medical, Inc., both Radius portfolio companies, as well as Immunicon, Inc., Protocare, Inc., and Purilens, Inc.
Vinod K. Sahney, Ph.D. is Senior Fellow at the Institute for Health Care Improvement (IHI). His previous positions include Senior Vice President and Chief Strategy Officer at Blue Cross Blue Shield of Massachusetts (2006-2010) and Senior Vice President at Henry Ford Health System (1981-2006). Dr. Sahney has been elected to both the Institute of Medicine and The National Academy of Engineering. He has served as an Adjunct Professor at Harvard University's Executive Program in Health Policy and Management for the past 33 years. He has served on several Boards including the Institute for Health Care Improvement, St. Joseph Mercy Hospital-Oakland, Fairlane Health Services Corporation, Society for Health Systems, Washington University School of Medicine Faculty Practice Plan, St. Joseph Macomb Hospital, Michigan Childrens, Henry Ford, Optimeyes and Healthsense, Inc., a Radius portfolio company. He has served on a number of National Research Advisory Boards including AHRQ, NSF, NAE and IOM. He has also authored two books, 50 publications and over 200 presentations at national and international meetings. He has been a management consultant to over 30 health care organizations in the area of strategy, productivity and quality improvement.
Leon G. Smith, M.D. is Chairman of Medicine and former Chief of Infectious Diseases at St. Michael’s Medical Center in Newark, NJ. He is also Chairman of Medicine at the Seton Hall University School of Graduate Medical Education and Professor of Preventative Medicine at New Jersey Medical School.
Mark S. Speers is Managing Director and co-founder of Health Advances, LLC, a strategy consulting firm focused on the evaluation and commercialization of new medical technologies and services. Previously, Mr. Speers served as a Partner at Bain & Company where he consulted for major health and life sciences companies.
Arthur H. Spiegel III founded APM Management Consultants in 1974 and grew the firm into the nation's largest stand-alone consulting firm dedicated to healthcare. In 1996, he sold APM to CSC, where, as President, he established and built the CSC Healthcare Group into one of the top four technology service companies in the industry. He also served in top management capacities for the city of New York and was one of the early leaders of ACCION International, a community development program. He currently sits on the boards of Accretive Health, Inc., Silverlink Communications, Inc., Sound Inpatient Physicians, Accolade Inc. and BioStorage, Inc., a Radius portfolio company.
Barry W. Wilson is the former Senior Vice President, International of Medtronic, Inc. He joined Medtronic, Inc. in 1995, as President Europe, Middle East & Africa. Previously, Mr. Wilson held executive-level positions with American Cyanamid Company (President, International of the Lederle Division), Bristol-Myers Squibb (President, Europe) and Pfizer. He currently serves as Honorary Chairman of Eucomed, the pan-European medical technology trade association, and has been a senior advisor to AdvaMed, the U.S. medical device association. Mr. Wilson was the former Chairman of Heartscape, Inc., a Radius portfolio company.